CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −412,584 | $1.15 | $474K | 2,095,999 |
| 2024-11-25 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −505 | $1.94 | $980 | 201,863 |
| 2024-11-25 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,371 | $1.94 | $3K | 827,200 |
| 2024-11-25 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,508 | $1.94 | $3K | 841,303 |
| 2024-11-25 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,371 | $1.94 | $3K | 824,212 |
| 2024-11-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −10,642 | $1.94 | $21K | 2,508,583 |
| 2024-11-24 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −721 | $1.88 | $1K | 202,368 |
| 2024-11-24 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,430 | $1.88 | $3K | 828,571 |
| 2024-11-24 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,787 | $1.88 | $3K | 842,811 |
| 2024-11-24 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,787 | $1.88 | $3K | 825,583 |
| 2024-11-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,473 | $1.88 | $14K | 2,519,225 |
| 2024-08-25 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,371 | $0.86 | $1K | 830,001 |
| 2024-08-25 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −493 | $0.86 | $424 | 193,923 |
| 2024-08-25 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,371 | $0.86 | $1K | 827,370 |
| 2024-08-25 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,508 | $0.86 | $1K | 844,598 |
| 2024-08-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,492 | $0.86 | $6K | 2,526,698 |
| 2024-08-24 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,430 | $0.86 | $1K | 831,372 |
| 2024-08-24 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −703 | $0.86 | $605 | 194,416 |
| 2024-08-24 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,787 | $0.86 | $2K | 828,741 |
| 2024-08-24 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,787 | $0.86 | $2K | 846,106 |
Page 6 of 9 · 165 trades